Structure | Chemical Name | CAS | MF |
|
2-CHLORO-6-(TRIFLUOROMETHYL)PHENYLISOTHIOCYANATE
|
688763-26-0
|
C8H3ClF3NS
|
|
3-TERT-BUTOXYCARBONYLAMINO-5-(4-ETHOXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID
|
688763-50-0
|
C18H21NO5S
|
|
Benzyl (1-(Methoxy(Methyl)Amino)-1-Oxopropan-2-Yl)Carbamate
|
688763-83-9
|
C13H18N2O4
|
|
Furan, tetrahydro-2-(3-methyl-2-methylenebutoxy)- (9CI)
|
688764-35-4
|
C10H18O2
|
|
1-Piperazineethanol,4-ethenyl-(9CI)
|
688772-66-9
|
C8H16N2O
|
|
Piperazine, 1-ethenyl-4-ethyl- (9CI)
|
688772-68-1
|
C8H16N2
|
|
2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-(pyridin-2-ylmethyl)acetamide
|
688773-27-5
|
C16H14N4O3
|
|
3-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-N-(pyridin-2-ylmethyl)propanamide
|
688773-75-3
|
C17H16N4O3
|
|
4-(2-FLUORO-4-AMINOPHENOXY)-7-AZAINDOLE
|
688781-75-1
|
C13H10FN3O
|
|
1H-Pyrrolo[2,3-b]pyridine, 6-chloro-4-nitro-
|
688781-87-5
|
C7H4ClN3O2
|
|
1H-Pyrrolo[2,3-b]pyridine, 3-methyl-, 7-oxide (9CI)
|
688782-00-5
|
C8H8N2O
|
|
4-Chloro-3-methyl-1H-pyrrolo[2,3-b]pyridine
|
688782-02-7
|
C8H7ClN2
|
|
4-(2-aMino-6-chloropyriMidin-4-yl)butanoic acid
|
688782-59-4
|
C8H10ClN3O2
|
|
4-chloro-6-cyclohexylpyrimidin-2-amine
|
688782-65-2
|
C10H14ClN3
|
|
2H-Pyran-3(6H)-one,5-ethoxy-(9CI)
|
688785-30-0
|
C7H10O3
|
|
Carbamic acid, (1R,3R,4S)-1-azabicyclo[2.2.1]hept-3-yl-, 1,1-dimethylethyl
|
688790-05-8
|
C11H20N2O2
|
|
exo-7-(tert-butoxycarbonyl)-7-aza-bicyclo[2.2.1]heptane-2-carboxylic acid methyl ester racemate
|
688790-06-9
|
C13H21NO4
|
|
2-BUTYNE-1,4-DIOL-(1,1,4,4)-D4
|
688790-78-5
|
C4H2D4O2
|
|
2-Naphthalenecarboxylicacid,5-amino-3-hydroxy-(9CI)
|
688794-58-3
|
C11H9NO3
|
|
2H-Pyran-5-carboxamide,N-cyclohexyl-4,6-dimethyl-2-oxo-(9CI)
|
688795-94-0
|
C14H19NO3
|
|
L-threo-Pentitol, 1,3,4-trideoxy-1,4-epithio-3-methylene- (9CI)
|
688797-27-5
|
C6H10O2S
|
|
Thiophene-3-ol, tetrahydro-4-(2-hydroxyethylidene)-, (3R)- (9CI)
|
688797-31-1
|
C6H10O2S
|
|
4-[(2-Bromophenyl)sulphonyl]morpholine
|
688798-57-4
|
C10H12BrNO3S
|
|
2-Bromo-N-ethyl-N-methylbenzenesulfonamide
|
688798-62-1
|
C9H12BrNO2S
|
|
3a(1H)-Pentalenecarboxylicacid,hexahydro-3-methylene-4-oxo-,methylester,(3aR,6aR)-rel-(9CI)
|
688799-51-1
|
C11H14O3
|
|
Bicyclo[3.2.1]octane-1-carboxylic acid, 7-methylene-2-oxo-, methyl ester (9CI)
|
688799-55-5
|
C11H14O3
|
|
Cyclopentanecarboxylic acid, 1-acetyl-2-ethyl-5-methylene-, methyl ester, (1R,2R)-rel- (9CI)
|
688799-56-6
|
C12H18O3
|
|
3-Buten-2-one, 4-(2-pyrimidinyl)-, (3E)- (9CI)
|
688800-76-2
|
C8H8N2O
|
|
3-NAPHTHALEN-2-YL-QUINOXALINE-5-CARBOXYLIC ACID
|
688801-18-5
|
C19H12N2O2
|
|
2(5H)-Furanone, 3-hydroxy-4-[(5-methyl-2-thienyl)carbonyl]- (9CI)
|
688801-94-7
|
C10H8O4S
|
|
3-METHOXY-PIPERIDINE HYDROCHLORIDE
|
688809-94-1
|
C6H14ClNO
|
|
(R)-3-Methoxypiperidine hydrochloride
|
688809-95-2
|
C6H14ClNO
|
|
(S)-3-Methoxypiperidine
|
688809-96-3
|
C6H13NO
|
|
3-(METHOXYMETHYL)PIPERIDINE HYDROCHLORIDE
|
688809-97-4
|
C7H16ClNO
|
|
2-(MethoxyMethyl)-piperidine HCl
|
688809-98-5
|
C7H16ClNO
|
|
(S)-2-(methoxymethyl)piperidinehydrochloride
|
688810-00-6
|
C7H16ClNO
|
|
3-Pyrrolidinol, 5-Methyl-, (3R,5R)-
|
688810-07-3
|
C5H11NO
|
|
Boronic acid, [4-(difluoromethoxy)phenyl]- (9CI)
|
688810-12-0
|
C7H7BF2O3
|
|
Cyclohexanecarboxaldehyde, 4-(hydroxymethyl)-, cis- (9CI)
|
688810-18-6
|
C8H14O2
|
|
Benzoic acid, 2-(dimethylamino)-4-ethyl-, methyl ester (9CI)
|
689148-76-3
|
C12H17NO2
|
|
8-Quinolinecarboxylicacid,1-ethyl-1,2,3,4-tetrahydro-,methylester(9CI)
|
689162-86-5
|
C13H17NO2
|
|
8-Quinolinecarboxylicacid,1-ethyl-1,2,3,4-tetrahydro-(9CI)
|
689162-91-2
|
C12H15NO2
|
|
3-Pyridinecarboxylicacid,6-methyl-2-[(1-methylethyl)amino]-(9CI)
|
689163-65-3
|
C10H14N2O2
|
|
2-Hexanol,2-(dimethylamino)-(9CI)
|
689207-16-7
|
C8H19NO
|
|
1H-Azepine-1-carboximidicacid,hexahydro-,hydrazide(9CI)
|
689208-02-4
|
C7H16N4
|
|
1,2-Cyclobutanediamine,N,N,N-trimethyl-,(1R,2R)-rel-(9CI)
|
689208-45-5
|
C7H16N2
|
|
2-Butenoicacid,2-[(dimethylamino)methyl]-3-methyl-(9CI)
|
689209-12-9
|
C8H15NO2
|
|
Ethanethioic acid, (dimethylamino)-, S-(2-aminoethyl) ester (9CI)
|
689212-46-2
|
C6H14N2OS
|
|
6-broMo-4-fluoroisoindoline
|
689214-92-4
|
C8H7BrFN
|
|
Cyclobutanecarboxylic acid, 1-amino-2-methyl-, (1R,2S)- (9CI)
|
689215-72-3
|
C6H11NO2
|
|
beta-D-erythro-Pentofuranoside, methyl 2-amino-2,3-dideoxy- (9CI)
|
689221-47-4
|
C6H13NO3
|
|
beta-D-erythro-Pentodialdo-1,4-furanoside, methyl 2-(benzoylamino)-2,3-dideoxy-
|
689221-52-1
|
C13H15NO4
|
|
beta-D-erythro-Pentofuranoside, methyl 2-(benzoylamino)-2,3-dideoxy- (9CI)
|
689221-53-2
|
C13H17NO4
|
|
2-(3-FLUOROPHENYL)PROPAN-2-AMINE HYDROCHLORIDE
|
689232-61-9
|
C9H13ClFN
|
|
tert-Butyl 2-(3-fluorophenyl)propan-2-ylcarbamate
|
689232-63-1
|
C14H20FNO2
|
|
Boronic acid, (4-acetyl-2-thienyl)- (9CI)
|
689247-77-6
|
C6H7BO3S
|
|
3-(4-fluorophenyl)-1-methyl-1H-pyrazole-4-carbaldehyde(SALTDATA: FREE)
|
689250-53-1
|
C11H9FN2O
|
|
5-(4-Methoxyphenyl)-1-Methyl-1H-Pyrazole-4-Carbaldehyde
|
689250-54-2
|
C12H12N2O2
|
|
1-Methyl-5-p-tolyl-1H-pyrazole-4-carbaldehyde
|
689250-61-1
|
C12H12N2O
|
|
1H-Pyrazole-4-carboxaldehyde,1-ethyl-5-(4-fluorophenyl)-(9CI)
|
689250-64-4
|
C12H11FN2O
|
|
Benzenamine, 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]- (9CI)
|
689251-51-2
|
C11H13N3O
|
|
Benzenamine, 4-[2-(5-ethyl-1,3,4-oxadiazol-2-yl)ethyl]- (9CI)
|
689251-59-0
|
C12H15N3O
|
|
Benzenamine, 4-[(4-ethyl-2-oxazolyl)methyl]- (9CI)
|
689251-67-0
|
C12H14N2O
|
|
Benzenamine, 4-[(2-ethyl-4-thiazolyl)methyl]- (9CI)
|
689251-68-1
|
C12H14N2S
|
|
1,3,4-Oxadiazol-2(3H)-one,5-[(4-aminophenyl)methyl]-3-ethyl-(9CI)
|
689251-70-5
|
C11H13N3O2
|
|
Benzenamine, 4-[(1-ethyl-1H-tetrazol-5-yl)methyl]- (9CI)
|
689251-72-7
|
C10H13N5
|
|
Benzenamine, 4-[(2-ethyl-2H-tetrazol-5-yl)methyl]- (9CI)
|
689251-73-8
|
C10H13N5
|
|
3-(1,5-DIMETHYL-1H-PYRAZOL-4-YL)-ACRYLIC ACID
|
689251-96-5
|
C8H10N2O2
|
|
(2E)-3-(1-METHYL-1H-PYRAZOL-4-YL)ACRYLIC ACID
|
689251-97-6
|
C7H8N2O2
|
|
2,3-DIFLUORO-4-METHOXYBENZYL BROMIDE
|
689254-23-7
|
C8H7BrF2O
|
|
Pyrido[3,4-b]indolizine (9CI)
|
689255-85-4
|
C11H8N2
|
|
Cyclohexanol,2-methoxy-1-(2-propenyl)-(9CI)
|
689256-52-8
|
C10H18O2
|
|
Cyclopropaneacetaldehyde, 2-(3-methoxyphenyl)-, (1R,2S)-rel- (9CI)
|
689258-86-4
|
C12H14O2
|
|
(2-chloro-6-methylpyridin-3-yl)methanol
|
689259-06-1
|
C7H8ClNO
|
|
Pyrido[2,3-b]pyrazin-3(2H)-one, 1,4-dihydro-1,6-dimethyl- (9CI)
|
689259-31-2
|
C9H11N3O
|
|
Pyrido[2,3-b]pyrazine, 1,2,3,4-tetrahydro-1,6-dimethyl- (9CI)
|
689259-32-3
|
C9H13N3
|
|
2-BroMo-5-iodo-1,3-diMethylbenzene
|
689260-53-5
|
C8H8BrI
|
|
N-[3-(propan-2-yloxy)propyl]-2-(pyridin-4-yl)quinoline-4-carboxamide
|
689268-84-6
|
C21H23N3O2
|
|
N-cyclohexyl-2-(pyridin-4-yl)quinoline-4-carboxamide
|
689269-17-8
|
C21H21N3O
|
|
4,4'-DIAMINO-2,2'-DI-(TRIFLUOROMETHYL)-DIPHENYLMETHANE
|
689275-08-9
|
C15H12F6N2
|
|
4-Quinolinamine,8-ethoxy-2-methyl-(9CI)
|
689277-01-8
|
C12H14N2O
|
|
4-AMINO-2,5,7-TRIMETHYLQUINOLINE
|
689277-04-1
|
C12H14N2
|
|
4-AMINO-2,6,8-TRIMETHYLQUINOLINE
|
689277-05-2
|
C12H14N2
|
|
Calcium(II) Bis(nonafluorobutanesulfonyl)imide
|
689282-13-1
|
C8H3CaF18NO4S2
|
|
4-N,N-Dimethylamino-2-(trimethylstannyl)-pyridine
|
689282-82-4
|
C10H18N2Sn
|
|
Tumor necrosis factor-α protease inhibitor-2, TNF-α protease inhibitor-2
|
689284-12-6
|
C19H37N5O5
|
|
2-Pentanone, 5-hydroxy-4-methyl-3-methylene- (9CI)
|
689290-33-3
|
C7H12O2
|
|
2-Pentanone, 5-hydroxy-3-methylene- (9CI)
|
689290-38-8
|
C6H10O2
|
|
4H-Furo[2,3-b][1]benzopyran-5,7-diol,2,3,3a,9a-tetrahydro-9a-methyl-,(3aR,9aR)-rel-(9CI)
|
689290-44-6
|
C12H14O4
|
|
2-Cyclopenten-1-one, 4-methyl-5-(2-methylpropylidene)-, (4R,5E)- (9CI)
|
689290-74-2
|
C10H14O
|
|
2-BROMO-6-(CHLOROMETHYL)NAPHTHALENE
|
689290-84-4
|
C11H8BrCl
|
|
Cyclohexanepentanoic acid, -ba--hydroxy-, (-ba-R)- (9CI)
|
689291-81-4
|
C11H20O3
|
|
5-BROMO-2-IODOBENZALDEHYDE
|
689291-89-2
|
C7H4BrIO
|
|
2-Cyclohexen-1-one, 6-hydroxy-3-methoxy-2-methyl- (9CI)
|
689293-30-9
|
C8H12O3
|
|
2-Cyclohexen-1-one, 6-hydroxy-3-methoxy-2-methyl-, (6R)- (9CI)
|
689293-32-1
|
C8H12O3
|
|
Ceftolozane Sulfate
|
689293-68-3
|
C23H30N12O8S2
|
|
N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester
|
689293-69-4
|
C31H36N6O3
|
|
Phenyl (5-aMino-1-Methyl-1H-pyrazol-4-yl)carbaMate, 95%
|
689294-25-5
|
C11H12N4O2
|
|
Formamide,N-(5-amino-1-methyl-1H-pyrazol-4-yl)-(9CI)
|
689294-31-3
|
C5H8N4O
|
|
1H-Pyrazol-5-amine,1-(2-fluoroethyl)-(9CI)
|
689295-20-3
|
C5H8FN3
|